BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 30, 2015

View Archived Issues

Bcl-2-like protein 11 is directly involved in beta cell apoptosis

Read More

TALENs used to disrupt gene for Rhesus D antigen in erythroid progenitor cells

Read More

Afferent Pharmaceuticals reports results from phase IIb trial of AF-219 in chronic cough

Read More

MPS1 inhibitor S-81694 begins first-in-human study for solid tumors

Read More

Advaxis initiates phase I study of ADXS-HER2 for HER2-expressing solid tumors

Read More

Aduro Biotech to acquire BioNovion

Read More

MedImmune and 3M Drug Delivery Systems collaborate to develop next-generation TLR agonists

Read More

Intercept Pharmaceuticals starts phase III trial of obeticholic acid in NASH with fibrosis

Read More

Verona releases data on new suspension formulation of RPL-554 in patients with COPD

Read More

FDA confirms data needed for Medidur NDA filing

Read More

BioMarin starts phase I/II trial of hemophilia A gene therapy BMN-270

Read More

Ablynx starts phase III trial of caplacizumab in acquired TTP

Read More

PDE4D is involved in Hedgehog signaling and could be targeted to treat medulloblastoma

Read More

CFTR gene therapy is associated with stabilization of lung function in phase IIb CF trial

Read More

F2G reports PK/PD profile of novel orotomide antifungal F-901318

Read More

IURTC and Assembly Biosciences patent HBV core protein allosteric modulators

Read More

Department of Health of the U.K. and JNCASR describe antimicrobial conjugates

Read More

Principia Biopharma reports TXK and ITK inhibitors

Read More

Merck & Co. and Merck Frosst Canada report HIV protease inhibitors

Read More

Takeda submits NDA for fixed-dose combination of Nesina and metformin in Japan

Read More

Endo confirms termination of waiting period for Par Pharmaceutical acquisition

Read More

Circulating miRNA levels associated with insulin resistance in metabolic syndrome

Read More

Maruho's Zebiax approved in Japan for bacterial skin infections

Read More

Topline results from third phase III trial of baricitinib for rheumatoid arthritis

Read More

Promising outcome in phase III ORATORIO study of ocrelizumab in primary progressive MS

Read More

FDA and EMA accept filings for rociletinib for NSCLC

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing